Cargando…
Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report
Psychedelic drugs such as psilocybin have shown substantial promise for the treatment of several psychiatric conditions including mood and addictive disorders. They also have the remarkable property of producing persisting positive psychological changes in healthy volunteers for at least several mon...
Autores principales: | McCulloch, Drummond E-Wen, Grzywacz, Maria Zofia, Madsen, Martin Korsbak, Jensen, Peter Steen, Ozenne, Brice, Armand, Sophia, Knudsen, Gitte Moos, Fisher, Patrick MacDonald, Stenbæk, Dea Siggaard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959755/ https://www.ncbi.nlm.nih.gov/pubmed/35355714 http://dx.doi.org/10.3389/fphar.2022.841648 |
Ejemplares similares
-
Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals
por: Søndergaard, Anna, et al.
Publicado: (2022) -
Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals
por: McCulloch, Drummond E-Wen, et al.
Publicado: (2021) -
Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation
por: Burmester, Daniel Rødbro, et al.
Publicado: (2022) -
Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial)
por: Jensen, Mathias Ebbesen, et al.
Publicado: (2022) -
Brain serotonin transporter is associated with cognitive‐affective biases in healthy individuals
por: Armand, Sophia, et al.
Publicado: (2022)